Earnings Estimate Revisions
Search documents
National Australia Bank (NABZY) Upgraded to Strong Buy: Here's Why
ZACKS· 2026-02-20 18:01
Core Viewpoint - National Australia Bank Ltd. (NABZY) has received a Zacks Rank 1 (Strong Buy) upgrade, indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which in turn affects the stock price [4]. Company Performance Indicators - For the fiscal year ending September 2026, National Australia Bank is expected to earn $0.90 per share, consistent with the previous year's reported figure [8]. - Over the past three months, the Zacks Consensus Estimate for National Australia Bank has increased by 15.4%, reflecting a positive trend in earnings estimates [8]. Zacks Rating System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [9][10].
Teva Pharmaceutical Industries (TEVA) Upgraded to Buy: Here's What You Should Know
ZACKS· 2026-02-20 18:01
Core Viewpoint - Teva Pharmaceutical Industries Ltd. has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which in turn affects stock prices [4]. Company Performance and Outlook - The upgrade for Teva implies an improvement in the company's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - Teva is expected to earn $2.72 per share for the fiscal year ending December 2026, with a 1.3% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7]. - Teva's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
All You Need to Know About Garmin (GRMN) Rating Upgrade to Buy
ZACKS· 2026-02-20 18:01
Core Viewpoint - Garmin (GRMN) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive shift in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Impact - Changes in a company's earnings potential, reflected in earnings estimate revisions, are strongly correlated with near-term stock price movements, particularly due to institutional investors' reliance on these estimates for valuation [3]. - The Zacks rating upgrade for Garmin suggests an improvement in the company's underlying business, which is expected to positively influence its stock price [4]. Importance of Earnings Estimate Revisions - Empirical research supports the correlation between earnings estimate revisions and stock movements, making it beneficial for investors to track these revisions for investment decisions [5]. - The Zacks Rank system effectively utilizes earnings estimate revisions to classify stocks, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. Specifics on Garmin's Earnings Estimates - For the fiscal year ending December 2026, Garmin is expected to earn $8.93 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 8.4% over the past three months [7]. Zacks Rating System Overview - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across its universe of over 4,000 stocks, with only the top 5% receiving a "Strong Buy" rating [8]. - Garmin's upgrade to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9].
McEwen (MUX) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2026-02-20 18:01
Core Viewpoint - McEwen (MUX) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which have a strong correlation with near-term stock price movements [4][6]. - Rising earnings estimates for McEwen suggest an improvement in the company's underlying business, potentially leading to higher stock prices [5]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - McEwen's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions for McEwen - For the fiscal year ending December 2025, McEwen is expected to earn -$0.01 per share, with no year-over-year change [8]. - Over the past three months, the Zacks Consensus Estimate for McEwen has increased by 9200%, reflecting a significant upward trend in earnings estimates [8].
Fluor (FLR) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2026-02-20 18:01
Core Viewpoint - Fluor (FLR) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade reflects an improvement in Fluor's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - Analysts have raised their earnings estimates for Fluor, with the Zacks Consensus Estimate increasing by 6.7% over the past three months [8]. Zacks Rank System - The Zacks Rank system categorizes stocks based on earnings estimates into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Fluor's upgrade places it in the top 5% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
Here's Why Sage Group (SGPYY) Is a Great 'Buy the Bottom' Stock Now
ZACKS· 2026-02-20 15:55
Shares of Sage Group PLC (SGPYY) have been struggling lately and have lost 7.2% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the futu ...
Wall Street Analysts See XPeng (XPEV) as a Buy: Should You Invest?
ZACKS· 2026-02-20 15:30
Core Viewpoint - The article discusses the reliability of Wall Street analysts' recommendations, particularly focusing on XPeng Inc. (XPEV), and highlights the potential misalignment of brokerage firms' interests with retail investors [1][5]. Group 1: Brokerage Recommendations - XPeng currently has an average brokerage recommendation (ABR) of 1.70, indicating a consensus between Strong Buy and Buy, based on 22 brokerage firms' recommendations [2]. - Out of the 22 recommendations, 14 are classified as Strong Buy and 2 as Buy, which represent 63.6% and 9.1% of the total recommendations respectively [2]. Group 2: Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the highest price increase potential [5]. - Analysts from brokerage firms often exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [6][11]. Group 3: Zacks Rank vs. ABR - The Zacks Rank is a proprietary stock rating tool that categorizes stocks based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][12]. - The ABR is based solely on brokerage recommendations and may not be up-to-date, while the Zacks Rank reflects timely earnings estimate revisions [13]. Group 4: Current Earnings Estimates for XPeng - The Zacks Consensus Estimate for XPeng has declined by 33.5% over the past month to -$0.23, indicating growing pessimism among analysts regarding the company's earnings prospects [14]. - This decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for XPeng, suggesting caution despite the Buy-equivalent ABR [15].
Stay Ahead of the Game With EOG Resources (EOG) Q4 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2026-02-20 15:16
Core Viewpoint - EOG Resources is expected to report quarterly earnings of $2.20 per share, reflecting a 19.7% decline year-over-year, while revenues are forecasted to increase by 3.9% to $5.8 billion [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 3.6% over the last 30 days, indicating analysts' reassessment of their initial forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Crude Oil and Condensate' will be $2.98 billion, down 8.5% from the previous year [5]. - 'Revenues- Natural Gas Liquids' are projected at $586.81 million, up 5.9% year-over-year [5]. - 'Revenues- Natural Gas' is expected to reach $903.74 million, showing a significant increase of 82.9% compared to the prior year [6]. - 'Revenues- Gathering, Processing and Marketing' is estimated at $1.32 billion, down 1.8% from the previous year [6]. Volume Estimates - 'Crude Oil and Condensate Volumes per day - Total' is expected to be 545.32 thousand barrels, up from 494.60 thousand barrels year-over-year [7]. - 'Crude Oil Equivalent Volumes per day - Total' is projected at 1,371.08 thousand barrels of oil equivalent, compared to 1,095.70 thousand barrels in the same quarter last year [8]. - 'Natural Gas Liquids Volumes per day - Total' is forecasted to reach 325.20 thousand barrels, up from 252.50 thousand barrels year-over-year [8]. Price Estimates - 'Average Natural Gas Liquids Prices per bbl - Composite' is expected to be $19.75, down from $23.85 in the previous year [9]. - 'Average Crude Oil and Condensate Prices per bbl - Composite' is projected at $59.51, compared to $71.66 in the same quarter last year [9][10]. - 'Total Production' is estimated to reach 126 thousand barrels of oil equivalent, up from 101 thousand barrels year-over-year [10]. Stock Performance - EOG Resources shares have increased by 16.5% over the past month, contrasting with a -0.8% change in the Zacks S&P 500 composite [11]. - The company holds a Zacks Rank 4 (Sell), indicating expectations of underperformance relative to the overall market in the near future [11].
Stay Ahead of the Game With FS KKR Capital (FSK) Q4 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2026-02-20 15:15
Core Viewpoint - FS KKR Capital (FSK) is expected to report a quarterly earnings per share (EPS) of $0.55, reflecting a year-over-year decline of 16.7%, with revenues projected at $361.27 million, down 11.2% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.7% lower in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Key Metrics Forecast - Analysts predict 'Investment income- Fee income' will reach $12.13 million, representing a significant year-over-year increase of 73.2% [4]. - The estimate for 'Investment income- Dividend and other income' is $75.64 million, indicating a slight decrease of 0.5% from the prior year [5]. - The consensus for 'Investment income- Paid-in-kind interest income' stands at $48.31 million, reflecting a substantial decline of 34.7% year-over-year [5]. - 'Investment income- Interest income' is expected to be $223.41 million, which is a decrease of 13.1% compared to the previous year [6]. Stock Performance - FS KKR Capital shares have decreased by 9% over the past month, contrasting with the Zacks S&P 500 composite's decline of 0.8% [6]. - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6].
Salesforce (CRM) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2026-02-20 15:15
The upcoming report from Salesforce (CRM) is expected to reveal quarterly earnings of $3.03 per share, indicating an increase of 9% compared to the year-ago period. Analysts forecast revenues of $11.17 billion, representing an increase of 11.7% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earnings release ...